Clinical Trial Detail

NCT ID NCT02177825
Title Study of Imatinib Mesylate in Neurofibromatosis Type I Patients Aged 2 to 21 With Plexiform Neurofibromas
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors St. Justine's Hospital
Indications
Therapies

Imatinib

Age Groups: child

No variant requirements are available.